SENSITIVITY OF HUMAN COMPLEMENT FACTOR H RELATED PROTEIN (BTA STAT) TEST AND VOIDED URINE CYTOLOGY IN THE DIAGNOSIS OF BLADDER CANCER-Reference-Cited by-同舟云学术

SENSITIVITY OF HUMAN COMPLEMENT FACTOR H RELATED PROTEIN (BTA STAT) TEST AND VOIDED URINE CYTOLOGY IN THE DIAGNOSIS OF BLADDER CANCER

Published:2000-06 Issue:6 Volume:163 Page:1689-1692
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

RAITANEN MIKA-P.¹,MARTTILA TIMO¹,KAASINEN EERO¹,RINTALA ERKKI¹,AINE RISTO¹,TAMMELA TEUVO L.J.¹,TAMMELA TEUVO L.J.¹,

Affiliation:

1. From the Division of Urology and Department of Pathology, Tampere University Hospital, Tampere, Department of Surgery, Seinäjoki Hospital, Hyvinkää Hospital and Department of Urology, Helsinki University Hospital, Helsinki, Finland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. Current status of urinary cytology in the evaluation of bladder neoplasms;Murphy;Hum Pathol,1990

2. Accuracy of cytological diagnosis of cancer of the urinary tract;Umiker;Acta Cytol,1964

3. Improved detection of recurrent bladder cancer using the Bard BTA stat Test;Sarosdy;Urology,1997

4. Complement factor H-related proteins are expressed in bladder cancer;Kinders;Proceedings of the annual meeting of American Association for Cancer Research, San Diego, California,1997

5. Human bladder tumor antigen is a member of the RCA (regulators of complement activation) gene family;Kinders;J Urol,1997

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study;Urologic Oncology: Seminars and Original Investigations;2023-12

2. Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-muscle-Invasive Bladder Cancer;Urothelial Carcinoma;2023

3. Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics;Journal of Proteome Research;2021-03-29

4. Identification of novel candidate circulating biomarkers for malignant soft tissue sarcomas: Correlation with metastatic progression;PROTEOMICS;2016-02

5. Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer;Oncotarget;2014-05-28